TCI Wealth Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
TCI Wealth Advisors's NVAX Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Novavax (NVAX) in Q2 2023, closing a stake of 27 shares — an estimated $188 sold.
TCI Wealth Advisors first reported a position in NVAX in Q2 2015 and held it in 20 quarters. The position peaked at $41K in Q4 2021. 215 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.
- TCI Wealth Advisors reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 27 Novavax shares in Q2 2023, an estimated $188.
- TCI Wealth Advisors first reported a position in Novavax in Q2 2015 and held it in 20 quarters.
- TCI Wealth Advisors's Novavax position peaked at $41K in Q4 2021.
- 215 funds tracked by Wall St. Rank held Novavax as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.